Literature DB >> 22366041

Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital.

Lucien Roulet1, Françoise Ballereau, Jean-Benoît Hardouin, Anne Chiffoleau, Leïla Moret, Gilles Potel, Nathalie Asseray.   

Abstract

OBJECTIVES: The frequency and the severity of drug-related visits in emergency department (ED) make the improvement of adverse drug event (ADE) recognition a crucial issue. As part of a research project aiming to improve the diagnosis and the management of ADEs in ED, the authors conducted a pilot study whose primary objective was to assess ADE recognition by emergency physicians.
METHODS: The patients presenting to the ED were included at randomised time periods between 1 October 2007 and 31 March 2008 in this prospective cross-sectional study. The primary outcome was the frequency of ADEs that were attributed to a medication-related problem by the emergency physician.
RESULTS: A total of 423 patients met the inclusion criteria, of which 95 experienced an ADE (22.5%; 95% CI 18.6% to 26.7%). Emergency physicians correctly attributed 33 of these cases (34.7%; 95% CI 25.3% to 45.2%) to a medication-related problem. Of the 28 cases in which the ADE was considered as a 'direct drug effect' (29.5%; 95% CI 20.6% to 39.7%), 16 were correctly identified by emergency physicians (57.1%; 95% CI 37.2% to 75.5%). Of the 67 cases in which the ADE was considered as a 'drug involvement in a multifactorial pathological condition' (70.5%; 95% CI 60.3% to 79.4%), 17 were correctly attributed (25.4%; 95% CI 15.5% to 37.5%).
CONCLUSIONS: ADEs are frequent in EDs and are not well recognised by emergency physicians, especially when the drug is involved in a multifactorial pathological condition.

Entities:  

Mesh:

Year:  2012        PMID: 22366041     DOI: 10.1136/emermed-2011-200482

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  11 in total

1.  Application of the Pareto principle to identify and address drug-therapy safety issues.

Authors:  Fabian Müller; Harald Dormann; Barbara Pfistermeister; Anja Sonst; Andrius Patapovas; Renate Vogler; Nina Hartmann; Bettina Plank-Kiegele; Melanie Kirchner; Thomas Bürkle; Renke Maas
Journal:  Eur J Clin Pharmacol       Date:  2014-03-21       Impact factor: 2.953

2.  Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization.

Authors:  Valentina Perrone; Valentino Conti; Mauro Venegoni; Stefania Scotto; Luca Degli Esposti; Diego Sangiorgi; Lucia Prestini; Sonia Radice; Emilio Clementi; Giuseppe Vighi
Journal:  Clinicoecon Outcomes Res       Date:  2014-12-03

Review 3.  Understanding adverse drug-related emergency department visits: development of a conceptual model through a systematic review.

Authors:  Abubakar Ibrahim Jatau; Zayyanu Shitu; Garba Mohammed Khalid; Ismaeel Yunusa; Ahmed Awaisu
Journal:  Ther Adv Drug Saf       Date:  2019-06-24

4.  Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.

Authors:  Ivan Lo Giudice; Eleonora Mocciaro; Claudia Giardina; Maria Antonietta Barbieri; Giuseppe Cicala; Maria Gioffrè-Florio; Giuseppe Carpinteri; Aulo Di Grande; Edoardo Spina; Vincenzo Arcoraci; Paola Maria Cutroneo
Journal:  BMC Pharmacol Toxicol       Date:  2019-04-27       Impact factor: 2.483

5.  Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).

Authors:  Niccolò Lombardi; Giada Crescioli; Alessandra Bettiol; Marco Tuccori; Annalisa Capuano; Roberto Bonaiuti; Alessandro Mugelli; Mauro Venegoni; Giuseppe Danilo Vighi; Alfredo Vannacci
Journal:  Front Pharmacol       Date:  2020-04-06       Impact factor: 5.810

6.  The use of Kampo medications that may cause heart failure in hospitalized acute heart failure patients in a Japanese hospital.

Authors:  Junpei Komagamine; Miho Kaminaga; Toshikazu Omori; Shinpei Tatsumi
Journal:  J Gen Fam Med       Date:  2020-12-09

7.  Preventable adverse drug events causing hospitalisation: identifying root causes and developing a surveillance and learning system at an urban community hospital, a cross-sectional observational study.

Authors:  Jane de Lemos; Peter Loewen; Cheryl Nagle; Robert McKenzie; Yong Dong You; Anna Dabu; Peter Zed; Peter Ling; Richard Chan
Journal:  BMJ Open Qual       Date:  2021-01

8.  Impact of systematic medication review in emergency department on patients' post-discharge outcomes-A randomized controlled clinical trial.

Authors:  Lisbeth Damlien Nymoen; Trude Eline Flatebø; Tron Anders Moger; Erik Øie; Espen Molden; Kirsten Kilvik Viktil
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

9.  Prevalence of hospitalisation caused by adverse drug reactions at an internal medicine ward of a single centre in Japan: a cross-sectional study.

Authors:  Junpei Komagamine; Masaki Kobayashi
Journal:  BMJ Open       Date:  2019-08-05       Impact factor: 2.692

10.  Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial.

Authors:  Cyril Breuker; Marie Faucanié; Marion Laureau; Damien Perier; Véronique Pinzani; Grégory Marin; Mustapha Sebbane; M Villiet
Journal:  Trials       Date:  2021-08-06       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.